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Intraocular pressure and ocular perfusion during hemodialysis
Pressão intraocular e perfusão ocular durante hemodiálise
CAROLINA PELEGRINI BARBOSA1, FRANCISCO ROSA STEFANINI1, FERNANDO PENHA1, MIGUEL ÂNGELO GÓES2, SÉRGIO ANTONIO DRAIBE2, MARIA EUGÊNIA CANZIANI2,
AUGUSTO PARANHOS JUNIOR1
RESUMO
Objetivo: Avaliar a pressão intraocular e a pressão de perfusão ocular durante uma
sessão de hemodiálise.
Métodos: Sessenta e sete olhos de trinta e cinco pacientes foram avaliados no início, após
2 horas e após 4 horas do início de uma sessão de hemodiálise. A pressão intraocular foi
avaliada usando o aparelho Tonopen. Pressões arteriais sistólica e diastólica foram aferidas
usando esfigmomanômetro manual. A pressão de perfusão ocular foi estimada por meio
do cálculo da diferença entre 2/3 da pressão arterial média e valores da pressão intraocular.
Equações de estimação generalizada foram usadas para avaliar a diferença entre medidas
repetidas usando correção apropriada para dependência entres olhos.
Resultados: Não houve diferença estatisticamente significativa na pressão de perfusão
ocular, PIO (p=0,93) e na pressão arterial sistólica (p=0,92) nos três períodos medidos da
hemodiálise (p=0,69). Mas, quando analisados valores extremos, alguns pacientes exibi-
ram pressões diastólicas menores em todos os períodos aferidos.
Conclusão: Nossos resultados não apontaram mudanças significativas na pressão de
perfusão ocular e pressão intraocular durante a hemodiálise. No entanto, foi observado
que alguns pacientes exibiram pressões diastólicas menores, o que pode ser um fator de
prognóstico ruim para pacientes com glaucoma.
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ABSTRACT
Aim: To evaluate the intraocular pressure and ocular perfusion pressure during a
hemodialysis.
Methods: Sixty-seven eyes from thirty-five patients were evaluated at the beggining
of hemodialysis, 2 hours and 4 hours after initiation. Intraocular pressure was evaluated
using a Tonopen. Systolic and diastolic arterial pressures were measured with a
manual sphygmomanometer. The ocular perfusion pressure was estimated by mea-
suring the difference between 2/3 of the mean arterial pressure and the intraocular
pressure values. Generalized estimating equations were used to evaluate the
difference between the repeated measurements using the appropriate correction
for inter-eye dependency.
Results: There was no statistically significant difference in ocular perfusion pressure,
in intraocular pressure (p=0.93) and in systolic arterial pressure (p=0.92) at the three
time points (p=0.69). But, when analyzing the extreme values, some patients exhibited
lower diastolic perfusion pressures at all time points.
Conclusion: Our results did not support the view that significant changes in ocular
perfusion pressure and intraocular pressure occur during hemodialysis session.
However, we observed that some patients exhibited lower diastolic perfusion pressures,
which could be a poor prognostic factor for glaucoma patients.
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INTRODUCTION
Hemodialysis (HD) is an effective treatment for end-stage renal
disease (ESRD). Although HD is a relatively safe procedure, several
complications could still arise, and acute complications common-
ly occur during routine HD treatments(1-2). These include hypoten-
sion (25-55% of cases), cramps (5-20%), nausea and vomiting (5-15%),
headache (5%), back pain (2-5%), chest pain (2-5%), itchiness (<5%),
and fever and chills (<1%)(3). More serious complications include
cardiac arrhythmia, convulsion, gaseous embolism, and intracra-
nial hemorrhage(3).
Arterial hypotension still represents a major complication resul-
ting from HD therapy; it frequently shortens the duration of dialysis
and increases patient mortality rates(4-5). The pathogenesis of hemo-
dynamic instability in response to fluid removal probably involves
many factors such as defective plasma refilling(6), abnormal body hea-
ting(7-8), an imbalance between endothelin and nitric oxide synthesis(9),
and defective adjustment of arteriovenous tone in response to the
changes in the effective plasma volume(10). An abrupt hypovolemia
should induce a sympathetic activation that increases the heart rate
and total peripheral resistance(10). This in turn prevents an imbalance
between the vascular capacitance and plasma underfilling, ultimately
resulting in the maintenance of arterial pressure(10).
Many complications from the development of hypotension du-
ring and after HD have been reported for adults(11), such as anterior
ischemic optic neuropathy (AION) and non-occlusive mesenteric is-
chemia, which is the major cause of acute abdominal injury in HD
patients(12). Intensive ultrafiltration is usually the factor that precipi-
tates hypotension in this patient population(12).
The hypothesis that hypoperfusion of the optic nerve head is a
risk factor for glaucoma is controversial. Several epidemiological
studies have revealed a strong correlation between glaucoma da-
mage and the presence of low diastolic arterial pressure, which gives
rise to inadequate ocular perfusion pressure (OPP)(13-14).
Alterations of OPP could cause ischemia: a poor irrigation of tissues
in the optic nerve, thus having deleterious effects. These could be
significant reasons for the onset of glaucoma, an optic neuropathy of
unknown origin, which presents a distinctive pattern of nerve changes
and visual field loss. One explanation for this pathogenesis concerns
the “vascular hypothesis” based on the fact that abnormal perfusion of
the optic disc would be a major cause of glaucomatous damage(15).
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In this study, we evaluate the intraocular pressure, ocular
perfusion pressure, systolic and diastolic arterial pressures in
patients with end-stage renal disease during hemodialysis.
METHODS
STUDY DESIGN
We performed an observational case series study on 67 eyes from
35 patients with end-stage renal disease (ESRD) during a maintenan-
ce HD session in “Rim e Hipertensão” Hospital at the Federal Univer-
sity of São Paulo, Brazil. HD patients received dialysis therapy for at
least three months and were dialyzed three times a week for 3-5 hours
per session. All patients had arteriovenous fistulae and used a poly-
sulfone hollow fiber dialyzer (F8- Fresenius®).
Exclusion criteria included: iridotomy; diagnosis of glaucoma or
other ophthalmological disorder that might affect the evaluated para-
meters and patients with positive serological tests for human immu-
nodeficiency virus, hepatitis B virus, or hepatitis C virus. Complete
ophthalmologic exam was performed. All patients underwent visual
acuity measurements with Snellen chart, biomicroscopic examina-
tion using slit lamp, fundoscopy and intraocular pressure measure-
ment (IOP).
IOP was measured using a Tonopen (Medtronic Solan TONO -
PEN XL Applanation tonometer, Joacksonville - Florida, USA), which
is a portable electronic applanation device. The IOP was measured
at three different times during the HD session: at the beginning, 2
hours after initiation, and 4 hours later at the end of the session.
Systolic arterial pressure, diastolic arterial pressure, and body
weight were also measured before and after HD. OPP was estima-
ted by measuring the difference between 2/3 of the mean arterial
pressure and the IOP values. Mean arterial pressure measurements,
which provide indication of overall circulatory pressure load, were
estimated by the formula: diastolic arterial pressure + 1/3 (systolic
pressure - diastolic pressure).
We considered the guidelines of the Joint National Committee
on Prevention, Detection, Evaluation and Treatment of High arterial
Pressure for this research, which describe normal arterial pressure
as systolic arterial pressure < 120 mmHg and diastolic arterial pres-
sure < 80 mmHg(16).  We considered for this research low diastolic
arterial pressure as ≤ 60 mmHg as another study(17).
All participants signed an informed consent form, which was
approved by the local human research ethics committee.
STATISTICAL ANALYSIS
Continuous variables were expressed as mean ± standard devia-
tion or as a percentage. Comparisons between the systolic arterial
pressure (SAP) at the three time points during the HD session were
evaluated using repeated measures analysis of variance (ANOVA).
IOP and OPP at the three time points were analyzed using gene-
ralized estimating equations (GEE) models to account for the de-
pendence between eyes from the same patient. SPSS 17.0 for Win-
dows (SPSS Inc, Chicago, Illinois, USA) was used for statistical analysis.
All probabilities (p-values) were considered to be statistically signi-
ficant if they were less than 0.05.
RESULTS
This study included 67 eyes from 35 patients (65.7% male and
34.3% female). The study group was of an average age of 49 ± 17 years
(Table 1). The predominant etiologies of ESRD were glomerulone-
phritis, diabetes mellitus and hypertension (Table 2). The average
duration of HD treatment was 63 ± 62 months (range; 1 to 288 months).
The body weight significantly decreased during the HD session
(p<0.001) (Table 3).  There was no significant variation in the average
arterial pressure during the HD session (p=0.16) (Table 4).
During HD, the IOP and OPP did not significantly vary (p=0.93
and 0.69, respectively) (Figure 1 and 2). There was no correlation
between the IOP and SAP variations (p=0.92).
We observed that three patients exhibited lower diastolic perfu-
sion pressure, which is a poor prognostic factor for glaucoma patients
but we did not find significant changes in OPP in ESRD patients
during a HD session, because average arterial pressure and IOP did
not change during this period. No patient presented low diastolic
pressure at the beginning of dialysis session.
DISCUSSION
Established risk factors for primary open-angle glaucoma include
evidence of elevated IOP, advanced age, race, and a positive family
history. Systemic hypertension, low arterial pressure, and the presen-
ce of other vascular diseases have also been proposed as risk factors;
however, their contribution is controversial and current data are
inconclusive(18-19). Results from clinical trials, including the Early Ma-
nifest Glaucoma Trial, suggest a potential role for vascular factors in
glaucoma progression, given the positive associations with low ocular
systolic perfusion pressure (as calculated from the arterial pressure
value minus the IOP value), low systolic arterial pressure, and car-
diovascular disease history(18).
Several groups have reported that low systemic arterial pressu-
re is a risk factor for glaucoma(20-24). Some authors reported that more
advanced disease, lower systolic arterial pressure, and increased
Table 1. Demographics parameters at baseline (n=35)
Demographics parameters
Age (years) 49 + 17
Male/female 23/12
Table 2. Etiologies of end-stage renal disease (ESRD) at
baseline (n=35)
Etiology of ESRD N of participants
Chronic glomerulonephritis 13 (37%)
Chronic interstitial nephritis 08 (23%)
Diabetes mellitus 08 (23%)
Hypertension 03 (08%)
Unkown 03 (08%)
N= number
Table 3. Average body weight during hemodialysis (HD)
Average body weight (kg)
Stage of hemodialysis (HD)  (p<0.001)
Before  HD session 64.5 + 16
Immediately after HD session 64.1 + 16
kg= kilograms
Table 4. Average arterial pressure during hemodialysis (HD)
Average arterial pressure (mmHg)
Stage of hemodialysis (HD) (p=0.16) Min and Max
Before HD session 136 x 83 (090-160 x 60-100)
2 hours after HD session 135 x 81 (100-180 x 60-120)
4 hours after HD session 131 x 78 (080-160 x 50-110)
mmHg= milimeters of mercury; Min= minimum;  Max=maximum
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IOP are the three main risk factors for disease progression(23). Other
authors reported that lower diastolic arterial pressure is a signi-
ficant risk factor for glaucoma(24). Both the Barbados Eye Study and
the Franmingham Eye Study(14,25) suggested that people with field
defects have significantly decreased arterial pressure/IOP ratios.
These epidemiological studies have revealed a strong correlation
between anatomicofunctional glaucoma damage and the presen-
ce of low diastolic arterial pressure, which collectively contribute
to inadequate OPP(14, 17).
Nowadays, the concept of OPP and its identification of this as an
important risk factor for the development and progression of glau-
coma have brought together the vascular and mechanical compo-
nents of glaucoma. Costa et al., believe that it is the balance between
IOP and arterial pressure, influenced by the autoregulatory capacity
of the eye that determine whether an individual will develop optic
disc damage or not(26).
Some authors suggested that glaucoma patients with an exag-
gerated nocturnal reduction in systemic arterial pressure have an
altered OPP outside the period of arterial pressure reduction, which
is possibly related to a general vascular dysregulation(27).
In addition to a circadian rhythm for arterial pressure where we
observe a nocturnal fall, we also have some situations during the HD
session in which we see a reduction in the average arterial pressure
value(4-5). Therefore, there is hypotension during the HD session. Many
studies were developed to evaluate whether HD induces consi-
derable changes in the IOP(28). Doshiro et al., evaluated the change in
IOP during HD and determined that the IOP significantly decreased
during HD(29). Some studies have reported that the hypotension fol-
lowing dialysis could cause ischemic optic neuropathy (AION) both in
children and adults. AION is an ischemic injury of the optic nerve head
caused by hypoperfusion of the posterior ciliary arteries(30).
The present study demonstrates that there is no significant change
in IOP or arterial pressure variation during the HD session. Therefo-
re, the OPP did not change either. However, some patients showed
a change in intraocular hypertension during the second hour of HD.
Some studies have speculated that the IOP in glaucoma patients
during HD would increase because of impaired outflow facility(29);
or because glaucoma patients show abnormal autoregulation(31).
The reasons for abnormal autoregulation in this disease are largely
unknown, but there is evidence that reducing IOP improves autore-
gulation in glaucoma patients(31). However, we did not observe this
result in our study because we did not have any patients with glau-
comatous disease.
Perfusion pressure and vascular resistance determine arterial
pressure.  Hemodialysis vascular resistance can change because of
the rheological properties of the arterial, so this can change arterial
pressure. But in this research the results have considered these
properties as many other researches(29,32). Ultimately, in this research,
8% of the patients had hypertension and they were using medi-
cations for this disease. It is true that some drugs could interpose
with the results but as many other researches we do not know if
these drugs can interfere in the results and we assumed that not
only hypertensive patients were using drugs but also those with
diabetes and other pathologies.
Another limitation in this research is that all the methodology
was made measuring the OPP based on systemic arterial pressure
and intraocular pressure (considering braquial artery as intraocular
pressure) but studies in human models offer some disadvantages,
because it is hard to manipulate perfusion pressure(31). Firstly, becau-
se several methods available to measure ocular arterial flow cannot be
applied in humans due to their invasive nature; secondly, because
humans have autoregulation mechanism(31). This is the ability of a
vascular bed to adapt its vascular resistance to with this background,
calculated OPP cannot be the same as real OPP. When an individual is
sitting or standing, the ocular arterial pressure is lower than the
brachial arterial pressure because of the effect of gravity (the hydros-
tatic column effect)(33). But, in this research, all  patients assumed the
same position, they did not change during the exam in an effort to
minimize those effects.
CONCLUSION
Our results did not support the view that significant changes in
ocular perfusion pressure or intraocular pressure occur during
hemodialysis. However, we observed that some patients exhibited
lower diastolic perfusion pressures, which could be a poor prognostic
factor for glaucoma patients.
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